|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 65.43 USD | -1.07% |
|
-0.08% | +18.66% |
| Apr. 17 | Ani Pharmaceuticals Insider Sold Shares Worth $1,500,589, According to a Recent SEC Filing | MT |
| Apr. 09 | ANI Pharmaceuticals, Inc. Announces the Launch of Baclofen Oral Suspension | CI |
On a per-share basis, the
The drugmaker posted revenue of
ANI shares have increased 15% since the beginning of the year. The stock has risen 7.5% in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from
Copyright by Automated Insights, Inc. All rights reserved., source
| 1st Jan change | Capi. | |
|---|---|---|
| +18.66% | 1.39B | |
| +25.61% | 672B | |
| +25.87% | 570B | |
| -5.24% | 360B | |
| +16.49% | 321B | |
| +8.28% | 300B | |
| +7.09% | 217B | |
| -9.12% | 204B | |
| +5.01% | 199B | |
| -8.75% | 149B |
ANI PHARMACEUTICALS, INC. 
